PATENT CLAIM ANALYSIS

Application Number: 16025455
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["514", "242000"]

Abstract:
The specification relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where Q, R, R 1  and R 2  have any of the meanings defined herein. The specification also relates to the use of such compounds and salts thereof to treat or prevent GLS1 mediated disease, including cancer. The specification further relates to crystalline forms of compounds of Formula (I) and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds and salts; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; intermediates useful in the manufacture of such compounds and salts; and to methods of treating GLS1 kinase mediated disease, including cancer, using such compounds and salts.

Claim (Index 8):
The method of  claim 1 , where R 2  is methyl.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 2.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15314562', '15363030', '15362989', '15363018', '15360332']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8224829410154718
- 35 USC 102 Novelty (BERT): 0.6305661356124632
- Combined Prediction Score: 0.803291260475171
- Mean Citation Score: 521.0507180000002
- Max Citation Score: 670.2159
- Similarity Product: 503.94513403419256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test